BRUSSELS--(BUSINESS WIRE)--Regulatory News: AKKA (Paris:AKA) (BSE:AKA) (ISIN:FR0004180537): Mauro Ricci, Chairman and CEO of AKKA, commented: “Today marks a turning point in AKKA's history as we ...
As fairy-tale biotech stories go, this is up there: You’re a small, ambitious startup getting a healthy $30 million series A round. Fast-forward less than a year, and you’re being bought for a quarter ...
Zogenix, an Emeryville, California–based rare-disease therapy specialist, will pay $250 million to acquire Modis Therapeutics, a start-up focused on rare genetic diseases. Modis’s lead candidate is ...
Fire maps like the one shown here accumulate the locations of the fires detected by the MODIS on board the Terra and Aqua satellites over a 10-day period. Each colored dot indicates a location where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results